Top

Published in:

01-06-2010 | Epidemiology

Coffee and tea intake and risk of breast cancer

Authors: Nirmala Bhoo Pathy, Petra Peeters, Carla van Gils, Joline W. J. Beulens, Yolanda van der Graaf, Bas Bueno-de-Mesquita, Awang Bulgiba, Cuno S. P. M. Uiterwaal

Published in: Breast Cancer Research and Treatment | Issue 2/2010

Abstract

Known risk factors account for about 10–15% of breast cancer incidence suggesting that lifestyle exposures are crucial in its etiology. Previous epidemiological studies on the association between coffee and tea consumption and breast cancer risk have been inconsistent. We investigated the association of coffee and tea consumption with the risk of breast cancer among women in EPIC-NL cohort, a population-based prospective cohort in Netherlands with 27,323 participants. Exposure was measured by a validated food frequency questionnaire, and the outcome was verified by direct linkage with the Netherlands Cancer Registry. A total of 681 invasive primary breast cancers were diagnosed in 9.6 years of follow-up. Coffee intake increased the risk of breast cancer by more than twofold as compared to non-consumers (HR; 2.25, 95% CI; 1.30–3.90). This association did not hold after multivariate adjustment which resulted in a HR of 1.17, 95% CI; 0.65–2.12. After adjustment to breast cancer risk factors and lifestyle, no association was observed between intake of coffee or tea and risk of breast cancer across all categories of intake. These results were also not altered by body mass index (BMI). Coffee and tea consumption does not seem to be related to the risk of breast cancer in women.

Parkin MD, Bray F, Ferlay J, Pisani P (2005) Global Cancer Statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed

World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR

McLaughlin CC, Mahoney MC, Nasca PC et al (1992) Breast cancer and methylxanthine consumption. Cancer Causes Control 3(2):175–178CrossRefPubMed

Ewertz M, Gill C (1990) Dietary factors and breast cancer risk in Denmark. Int J Cancer 46(5):779–784CrossRefPubMed

Tavani A, Pregnolato A, La Vecchia C et al (1998) Coffee consumption and the risk of breast cancer. Eur J Cancer Prev 7(1):77–82PubMed

Wu AH, Yu MC, Tseng CC et al (2003) Green tea and risk of breast cancer in Asian Americans. Int J Cancer 106:574–579CrossRefPubMed

Mannisto S, Pietinen P, Virtanen V et al (1999) Diet and the risk of breast cancer in a case-control study: does the threat of disease have an influence on recall bias? J Clin Epidemiol 52:429–439CrossRefPubMed

Kumar N, Titus-Ernstoff L, Newcomb PA et al. (2009) Tea consumption and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 18(1):341–345

Baker JA, Beehler GP, Sawant AC et al (2006) Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J Nutr 136:166–171PubMed

10.

Zhang M, Holman CDJ, Huang JP, Xie X (2007) Green tea and the prevention of breast cancer: a case control study in Southeast China. Carcinogenesis 28(5):1074–1078CrossRefPubMed

11.

Rosenberg L, Miller DR, Helmrich SP et al (1985) Breast cancer and the consumption of coffee. Am J Epidemiol 122(3):391–399PubMed

12.

Zheng W, Doyle TJ, Kushi LH et al (1996) Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 144:175–182PubMed

13.

Folsom AR, McKenzie DR, Bisgard KM et al (1993) No association between caffeine intake and postmenopausal breast cancer incidence in the Iowa Women’s Health Study. Am J Epidemiol 138:380–383PubMed

14.

Suzuki Y, Tsubono Y, Nakaya N et al (2004) Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer 90:1361–1363CrossRefPubMed

15.

Ganmaa D, Willet WC, Li TY et al (2008) Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 122:2071–2076CrossRefPubMed

16.

Ishitani K, Lin J, Manson JE (2008) Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med 168(18):2022–2031CrossRefPubMed

17.

Michels KB, Holmberg L, Bergkvist L et al (2002) Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish Women. Ann Epidemiol 12(1):21–26CrossRefPubMed

18.

Hirvonen T, Mennen LI, de Bree A et al (2006) Consumption of antioxidant-rich beverages and risk for breast cancer in French women. Ann Epidemiol 16:503–508CrossRefPubMed

19.

Vatten LJ, Solvoll K, Loken EB (1990) Coffee consumption and the risk of breast cancer. A prospective study of 14, 593 Norwegian women. Br J Cancer 62(2):267–270PubMed

20.

Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:2073–2085

21.

Welsch CW, Scieszka KM, Senn ER et al (1983) Caffeine (1, 3, 7-trimethylxanthine), a temperate promoter of DMBA-induced rat mammary gland carcinogenesis. Int J Cancer 32(4):479–484CrossRefPubMed

22.

Trosko JE, Chu HY (1973) Inhibition of repair of UV-damaged DNA by caffeine and mutation induction in Chinese hamster cells. Chem Biol Interact 6(5):317–322CrossRefPubMed

23.

Wang LQ (2002) Mammalian phytoestrogens: enterodiol and enterolactone. J Chromatogr B Analyt Technol Biomed Life Sci 777(1–2):289–309PubMed

24.

Adlercreutz H (2002) Phyto-oestrogens and cancer. Lancet Oncol 3:364–373CrossRefPubMed

25.

Brooks JD, Thompson LU (2005) Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 94(5):461–467CrossRefPubMed

26.

Riboli E, Kaaks R (1997) The EPIC project: rationale and study design. Int J Epidemiol 26:S6–S14CrossRefPubMed

27.

Boker LK, Van Noord PAH, Van Der Schouw YT et al (2001) Prospect-EPIC Utrecht: study design and characteristics of the cohort population. Eur J Epidemiol 17:1047–1053CrossRefPubMed

28.

Blokstra A, Seidell JC, Smit HA et al. (1998) The monitoring project on risk factors for chronic diseases (MORGEN project) annual report 1997 (in Dutch). RIVM (National Institute for Public Health and the Environment), Bilthoven, Netherlands

29.

Ocké MC, Bueno-de-Mesquita HB, Goddijn HE et al (1997) The Dutch EPIC Food Frequency Questionnaire I. Description of the questionnaire, and relative validity and reproducibility for food groups. Int J Epidemiol 26:S37–S48CrossRefPubMed

30.

Ocké MC, Bueno-de-Mesquita HB, Pols MA, Smit HA, Van Staveren WA, Kromhout D (1997) The Dutch EPIC Food Frequency Questionnaire II. Relative validity and reproducibility for nutrients. Int J Epidemiol 26:S49–S58CrossRefPubMed

31.

Fitzmaurice G (2006) Confounding: propensity score adjustment. Nutrition 22:1214–1216CrossRefPubMed

32.

D’Agostino RB (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265–2281CrossRefPubMed

33.

Kurth T, Walker AM, Glynn RJ et al (2006) Results of multivariable logistic regression, propensity matching, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163:262–270CrossRefPubMed

34.

Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228SPubMed

35.

Tang N, Zhou B, Wang B, et al. (2009) Coffee consumption and risk of breast cancer: a metaanalysis. Am J Obstet Gynecol 200(3):290.e1–290.e9

36.

Luo J, Inoue M, Iwasaki M et al (2007) Green tea and coffee intake and risk of pancreatic cancer in a large scale, population based cohort study in Japan (JPHC study). Eur J Cancer Prev 16(6):542–548CrossRefPubMed

Title: Coffee and tea intake and risk of breast cancer
Authors: Nirmala Bhoo Pathy
Petra Peeters
Carla van Gils
Joline W. J. Beulens
Yolanda van der Graaf
Bas Bueno-de-Mesquita
Awang Bulgiba
Cuno S. P. M. Uiterwaal
Publication date: 01-06-2010
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 2/2010
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-009-0583-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2010

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

The association of metabolic syndrome with triple-negative breast cancer

Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer

Meta-analysis of vitamin D, calcium and the prevention of breast cancer

Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer

No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk

Keynote webinar | Spotlight on antibody–drug conjugates in cancer